HemaSphere
(Jun 2022)
PB1976: CRISPR-CAS9 KNOCKOUT SCREEN IDENTIFIES RNA MODIFICATION ENZYMES ESSENTIAL FOR CELL SURVIVAL IN MULTIPLE MYELOMA
- D. Zhao,
- C. Pauli,
- C. Rohde,
- M. Kienhöfer,
- A. L. Grab,
- S. Huhn,
- M. Raab,
- N. Weinhold,
- M. Frye,
- C. Müller-Tidow
Affiliations
- D. Zhao
- 1 Department of Medicine V, Hematology, Oncology and Rheumatology, Heidelberg University Hospital
- C. Pauli
- 1 Department of Medicine V, Hematology, Oncology and Rheumatology, Heidelberg University Hospital
- C. Rohde
- 1 Department of Medicine V, Hematology, Oncology and Rheumatology, Heidelberg University Hospital
- M. Kienhöfer
- 1 Department of Medicine V, Hematology, Oncology and Rheumatology, Heidelberg University Hospital
- A. L. Grab
- 1 Department of Medicine V, Hematology, Oncology and Rheumatology, Heidelberg University Hospital
- S. Huhn
- 1 Department of Medicine V, Hematology, Oncology and Rheumatology, Heidelberg University Hospital
- M. Raab
- 1 Department of Medicine V, Hematology, Oncology and Rheumatology, Heidelberg University Hospital
- N. Weinhold
- 1 Department of Medicine V, Hematology, Oncology and Rheumatology, Heidelberg University Hospital
- M. Frye
- 2 German Cancer Research Center—Deutsches Krebsforschungszentrum (DKFZ), Heidelberg, Germany
- C. Müller-Tidow
- 1 Department of Medicine V, Hematology, Oncology and Rheumatology, Heidelberg University Hospital
- DOI
-
https://doi.org/10.1097/01.HS9.0000850740.32198.44
- Journal volume & issue
-
Vol. 6
pp.
1849
– 1850
WeChat QR code